Questions? Call us at 800-810-7790
Blog
Featured

Jardiance and other SGLT2 Inhibitors

SGLT2 (sodium-glucose co-transporter 2) inhibitors are medicines used to help people with type 2 diabetes control their blood sugar levels. Some common brand names include Jardiance, Invokana, Farxiga, and Brenzavvy, and right now, there aren't any generic versions available. These medications are meant to be taken alongside a healthy diet and exercise.

Oct 3, 2023

Lithium for Bipoloar Disorder

Mar 1, 2024

Lithium is a mood-stabilizing medication that helps to reduce the severity and frequency of mania. It is prescribed for treating acute manic episodes and managing bipolar disorder. It’s an effective treatment option for bipolar disorder. However, due to its narrow range of safety, side effects, and newer medications it isn’t as widely used as it once was.

Pradaxa is Now Generic

Feb 27, 2024

Pradaxa is an anticoagulant (blood thinner) used to prevent stroke and harmful blood clots. It is also used to treat blood clots in the veins of your legs or lungs and to reduce the risk of them occurring again. Pradaxa became generic in the second quarter of 2022

What Causes Acne?

Feb 23, 2024

Acne primarily develops in adolescents during puberty. Androgens (male sex hormones) are the primary determinant of acne along with the presence of the bacteria P. acnes, and fatty acids (sebum) present in oil (sebaceous) glands. Acne mainly appears on your face, chest, shoulders, and back. Diets with a high glycemic index or dairy can worsen acne.

What You Need to Know about Cimetidine

Feb 20, 2024

Cimetidine (Tagamet) is a commonly prescribed medication in the US. It’s a type of medication called a histamine-2 receptor antagonist (H2RA) and is prescribed to treat a number of different digestive system issues. The main thing that these issues have in common is a negative response to the highly acidic contents of your stomach. While this acid is great for digesting food, it can be very damaging if it gets anywhere it shouldn’t be.

7 Facts About Valproic Acid

Feb 14, 2024

Valproic acid (VPA) is an anti-seizure medication to treat seizures in two specific patient populations: For patients with absence seizures and tonic clonic seizures, and for patents with multiple types of seizures

Types of Heart Attacks: STEMI and NSTEMI

Feb 8, 2024

Heart attacks, medically termed myocardial infarctions (MIs), are among the most urgent medical emergencies worldwide. With the American Heart Association reporting a heart attack every 40 seconds in the United States, awareness and understanding are key.

Framingham Risk Score

Jan 31, 2024

The Framingham Risk Calculator, also known as the Framingham Risk Score, is a widely used tool for estimating an your risk of developing cardiovascular disease (CVD), specifically coronary heart disease (CHD) or stroke, over a certain period of time. It is named after the town of Framingham, Massachusetts, where the Framingham Heart Study was conducted.

7 Important Facts About Divalproex

Jan 29, 2024

Divalproex is an anti-seizure medication that has been approved by the FDA to treat various medical conditions. This includes treatment for seizures in two specific patient populations.

Understanding Pemphigus: Types, Causes, and Symptoms

Jan 26, 2024

Pemphigus is an uncommon autoimmune disorder that primarily affects your skin and mucous membranes. It causes painful blisters and sores due to the immune system mistakenly attacking healthy cells in your skin's top layer (epidermis) and mucous membranes.

Using Glipizide for Type 2 Diabetes

Jan 22, 2024

Glipizide belongs to a group of drugs called sulfonylureas. These drugs are designed to help manage type 2 diabetes by interacting with the body's natural processes for controlling blood sugar.

Leqembi: A Turning Point in Alzheimer's Treatment

Jan 18, 2024

On January 6, 2023, the U.S. Food and Drug Administration (FDA) made a significant step forward in Alzheimer's treatment by initially approving Leqembi via the Accelerated Approval Pathway. This was followed by a traditional approval on July 6, 2023.

What is Enulose and What is it For?

Jan 15, 2024

Enulose, known by its generic name lactulose, is a special kind of sugar that our bodies cannot digest or absorb. It's primarily used as a medication for gut-related problems and comes in the form of an oral solution.

Understanding ALS

Jan 11, 2024

ALS is a progressive neurological disease that affects nerve cells in your brain and spinal cord. This condition primarily impacts your motor neurons responsible for voluntary muscle movement, leading to muscle weakness, paralysis, and eventually respiratory failure.

Hydroquinone and Skin Health

Jan 10, 2024

Hydroquinone, known commercially as Eldoquin Forte, is a skin-lightening medication used to treat hyperpigmentation. It works by disrupting melanin production, the pigment responsible for skin, hair, and eye color.

What Can You Do About Hemorrhoids?

Jan 8, 2024

Hemorrhoids are an uncomfortable condition that effects almost half the population at some point by the age of 50. Hemorrhoids are characterized by bulging swollen blood vessels in and/or around your anus and can be very uncomfortable.

Questions About Dysmenorrhea

Jan 4, 2024

Dysmenorrhea is the term used to describe very painful menstrual periods. Most people with periods experience some level of discomfort before and/or during their period. For some people, this pain and discomfort is beyond what is considered “normal”, to the point where it can be debilitating. This condition is more common than you might think and can affect up to 90% of women at some point in their reproductive years. Of this, up to 29% have particularly severe dysmenorrhea.

Using Glimepiride for Type 2 Diabetes

Jan 2, 2024

Glimepiride is a medication specifically designed for managing type 2 diabetes. It's often used in combination with lifestyle changes like a healthy diet and regular exercise. Though it's an older drug, it can be particularly useful for certain individuals, especially when other diabetes medications aren't suitable.